Rare diseases
Investigational molecules
Locations
Back to Italy7 clinical trials in Mantova, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer
ItalyStudy on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding
ItalyStudy of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer
ItalyStudy of cemiplimab with or without chemotherapy for non-small cell lung cancer patients with high PD-L1 levels to reduce rapid disease progression
ItalyStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
ItalyStudy on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma
ItalyStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on severe asthma treatments, particularly examining new therapeutic options for patients with eosinophilic phenotype. Studies are evaluating the effectiveness of novel medications compared to established treatments.
Current trials are exploring both maintenance therapy optimization and new treatment approaches for inadequately controlled asthma.
Advanced research in metastatic colorectal cancer treatment, comparing different combination therapies. Studies focus on personalized treatment approaches based on genetic markers.
Investigations aim to optimize treatment selection for previously untreated metastatic disease.
Dual-focus research examining both intracerebral hemorrhage treatments and chronic urticaria management. Novel therapeutic approaches are being tested for both conditions.
Studies aim to improve patient outcomes in both acute neurological emergencies and chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
